Peptide Technologies vs Zhejiang Yichenkang
Independent side-by-side comparison across the 0 peptides both vendors sell. Composite scores, lab quality, and verified pricing.
Peptide Technologies
5 BPC-157 tests with score variance 5.0–10.0. GHK-Cu and Ipamorelin coverage solid.
Peptide Technologies full review →Side-by-side breakdown
| PEPTIDE | PEPTIDE TECHNOLOGIES | ZHEJIANG YICHENKANG | WINNER |
|---|---|---|---|
| GHK-Cu |
7.4
B (6 tests)
|
—(not sold)
|
Peptide Technologies only |
| BPC-157 |
6.5
B (5 tests)
|
—(not sold)
|
Peptide Technologies only |
| Tirzepatide |
—(not sold)
|
8.2
B+ (8 tests)
|
Zhejiang Yichenkang only |
Which to choose
Across the 0 peptides both vendors sell, Peptide Technologies scores higher on 0, Zhejiang Yichenkang scores higher on 0, and 0 are within 0.3 points (effectively tied). Zhejiang Yichenkang additionally sells Tirzepatide; Peptide Technologies does not. Peptide Technologies additionally sells GHK-Cu, BPC-157; Zhejiang Yichenkang does not.
Composite scores reflect lab quality, sentiment, COA transparency, reliability, and price. How we score.
Full profiles: Peptide Technologies review · Zhejiang Yichenkang review